Cargando…
Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation
OBJECTIVE: Serum procollagen type I N-terminal propeptide (PINP), a representative marker of bone anabolic action, is strongly related to bone mineral density during teriparatide therapy. This post hoc study analyzed data from a Phase III study (ClinicalTrials.gov identifier NCT00433160) to determin...
Autores principales: | Yamamoto, Takanori, Tsujimoto, Mika, Sowa, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500620/ https://www.ncbi.nlm.nih.gov/pubmed/26185429 http://dx.doi.org/10.2147/CIA.S83549 |
Ejemplares similares
-
Chronic hypoparathyroidism and treatment with teriparatide
por: Marcucci, Gemma, et al.
Publicado: (2021) -
Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan, Tomaz, et al.
Publicado: (2021) -
Treatment of spontaneous osteonecrosis of the knee by daily teriparatide: A report of 3 cases
por: Horikawa, Akira, et al.
Publicado: (2020) -
Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007) -
Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip
por: Yatsushiro, Shouki, et al.
Publicado: (2011)